A PYMNTS Company

US: GSK loses bid to overturn ruling in antitrust case

By  |  February 8, 2018

On Wednesday,  February 7, Reuters reported that a federal appeals court said it will not reconsider a decision to allow the state of Louisiana to bring antitrust claims against GlaxoSmithKline.

The 3rd US Circuit Court of Appeal in Philadelphia rejected GSK’s bid to have the full court to review a decision holding Louisiana’s sovereign immunity meant it was not bound by a deal resolving claims the drugmaker tried to delay generic versions of its allergy spray Flonase.

Full Content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.